Led by Greenspring Associates, Xometry has just announced $50MM raised in equity funding. Also funding the on-demand manufacturing marketplace are:
- Dell Technologies Capital
- BMW i Ventures
- Foundry Group
- GE Ventures
- Highland Capital Partners
- Maryland Venture Fund
- Almaz Capital
Founded in 2014 as a manufacturing startup and headquartered in Maryland, Xometry has now raised a total of $113MM, leading us to wonder how they will designate these funds in relation to research and development—a question answered succinctly by Randy Altschuler, co-founder and CEO of Xometry:
“Xometry’s vast network, massive data sets and AI breakthroughs make it easier for engineers and designers to buy custom manufacturing and help manufacturers more efficiently operate their businesses. We’re planning to invest these funds behind growth initiatives, product development and global expansion.”
Allowing for everyone to benefit from custom manufacturing, Xometry has created a successful building model for being able to produce smaller, detailed numbers of parts for consumers rather than requiring mass orders due to profitability requirements like most product manufacturers today—and especially those still using more conventional methods aside from 3D printing and additive manufacturing. The Xometry team is able to meet on-demand needs for parts to a customer base spanning from startups to Fortune 100 companies.
“Xometry has quickly become a key player in the $80B custom manufacturing market,” said Hunter Somerville, General Partner for Greenspring Associates, who will also join Xometry’s Board of Directors.. “We’re thrilled to invest in helping them expand the reach and breadth of their marketplace and the services it offers.”
- 3D printing services
- Traditional CNC machining processes
- Sheet metal fabrication
- Injection molding
- Die casting
- Urethane casting
“Xometry is yet another example of how machine learning based intelligent software is driving huge efficiency gains across many different industries,” said Daniel Docter, Managing Director Dell Technologies Capital. “We look forward to helping Xometry expand into new verticals that leverage the expertise of Dell Technologies.”
Their growth has continued at rapid speed, with revenue doubling in just the past year. The Xometry team has also created a spin-off with Xometry Supplies—meant to offer Xometry customers with materials and tools for manufacturing more rapidly, and affordably.
We have been following Xometry’s 3D printing progress for years, since they transformed from NextLine Manufacturing into their current and dynamic state, as the largest custom manufacturing marketplace available to consumers today. From streamlining the way engineers order 3D printed parts to changing the rules in manufacturing and even guiding us in choosing the best 3D printing materials, Xometry is geared toward making life easier for engineers and designers, catering to their specific needs.
What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.[Source / Images: Xometry]
You May Also Like
Engineer Spent Over 900 Hours Designing and 3D Printing Miniature Roller Coaster
If it ever comes up in conversation, I will freely admit that I am a total roller coaster junkie. I love them—the higher and crazier, the better. Give me inversions,...
Direct Image Sintering: Visitech Introduces New DLP-PBF 3D Printing Tech
In fall 2020, Visitech quietly made news with the release of a scrolling DLP projector capable of sintering plastic powder, potentially opening up new levels of throughput and reduced cost...
Readily3D Bioprinting Pancreas to Help EU-Funded Program Develop Diabetes Treatment
As the World Health Organization reports, the prevalence of diabetes has been rising over the last few decades, and there are currently around 422 million people around the world who...
ROKIT Healthcare’s bioprinting-based diabetic foot treatment kit registered as a U.S. FDA medical device
ROKIT Healthcare has completed registration of its Dr. INVIVO-based diabetic foot treatment with the U.S. FDA and has successfully completed clinical studies in the U.S. Since 2019, the company has...
View our broad assortment of in house and third party products.